Pulmokine Receives $1 Million Investment from Broadview Ventures to Advance PAH Candidate into First Clinical Trial Rensselaer, NY, March 3, 2015 (GLOBE NEWSWIRE) -- Pulmokine announced today that it has entered into an investment agreement with Broadview Ventures for $1 Million. Proceeds will be used to...

Pulmokine Awarded $1.5 Million Stage B VITA Contract to Advance Inhaled Kinase Inhibitors for Pulmonary Arterial Hypertension Rensselaer, NY, March 27, 2014 (GLOBE NEWSWIRE) -- Pulmokine announced it has been awarded a Stage B Vascular Interventions and Therapeutic Advances (VITA) contract from the National Heart, Lung, and...